EDGAR Filing Documents for 0001104659-21-135511

Form SC 13G - Statement of Beneficial Ownership by Certain Investors:

SEC Accession No. 0001104659-21-135511

Filing Date

2021-11-08

Accepted

2021-11-08 13:11:00

Documents

Group Members

ANDREW J. M. SPOKESDAVID T. KIMFARALLON CAPITAL (AM) INVESTORS, L.P.FARALLON CAPITAL F5 MASTER I, L.P.FARALLON CAPITAL INSTITUTIONAL PARTNERS II, L.P.FARALLON CAPITAL INSTITUTIONAL PARTNERS III, L.P.FARALLON CAPITAL INSTITUTIONAL PARTNERS, L.P.FARALLON CA

Document Format Files

Seq	Description	Document	Type	Size
1	SC 13G	tm2131987d1_sc13g.htm	SC 13G	291052
2	EXHIBIT 1	tm2131987d1_ex1.htm	EX-99.1	9699
	Complete submission text file	0001104659-21-135511.txt		303493

Mailing Address C/O FARALLON PARTNERS, L.L.C. ONE MARITIME PLAZA, SUITE 2100 SAN FRANCISCO CA 94111

Business Address C/O FARALLON PARTNERS, L.L.C. ONE MARITIME PLAZA, SUITE 2100 SAN FRANCISCO CA 94111 (415) 421-2132

Farallon Capital Partners, L.P. (Filed by) CIK: 0001175707 (see all company filings)

IRS No.: 943106322 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 311 WEST 43RD STREET, 12TH FLOOR NEW YORK NY 10036

Business Address 311 WEST 43RD STREET, 12TH FLOOR NEW YORK NY 10036 646-493-6558

Better Therapeutics, Inc. (Subject) CIK: 0001832415 (see all company filings)